Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110971432 | 11097143 | 2 | F | 200704 | 20160909 | 20150507 | 20160916 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-23329BP | BOEHRINGER INGELHEIM | 70.00 | YR | M | Y | 102.50000 | KG | 20160916 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110971432 | 11097143 | 1 | PS | MOBIC | MELOXICAM | 1 | Oral | 15 MG | 20938 | 15 | MG | QD | |||||||
| 110971432 | 11097143 | 2 | SS | MOBIC | MELOXICAM | 1 | Unknown | 20938 | |||||||||||
| 110971432 | 11097143 | 3 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 110971432 | 11097143 | 4 | SS | NAPROXEN. | NAPROXEN | 1 | Y | 0 | |||||||||||
| 110971432 | 11097143 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | |||||||||||
| 110971432 | 11097143 | 6 | C | PROCARDIA | NIFEDIPINE | 1 | Unknown | 0 | |||||||||||
| 110971432 | 11097143 | 7 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | |||||||||||
| 110971432 | 11097143 | 8 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 | |||||||||||
| 110971432 | 11097143 | 9 | C | AVAPRO | IRBESARTAN | 1 | Unknown | 0 | |||||||||||
| 110971432 | 11097143 | 10 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | 0 | |||||||||||
| 110971432 | 11097143 | 11 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 0 | 325 | MG | |||||||||
| 110971432 | 11097143 | 12 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | Sublingual | 0 | .4 | MG | |||||||||
| 110971432 | 11097143 | 13 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110971432 | 11097143 | 1 | Osteoarthritis |
| 110971432 | 11097143 | 3 | Osteoarthritis |
| 110971432 | 11097143 | 4 | Rheumatoid arthritis |
| 110971432 | 11097143 | 5 | Prophylaxis |
| 110971432 | 11097143 | 6 | Product used for unknown indication |
| 110971432 | 11097143 | 7 | Product used for unknown indication |
| 110971432 | 11097143 | 8 | Product used for unknown indication |
| 110971432 | 11097143 | 9 | Product used for unknown indication |
| 110971432 | 11097143 | 10 | Rhinitis allergic |
| 110971432 | 11097143 | 11 | Product used for unknown indication |
| 110971432 | 11097143 | 12 | Product used for unknown indication |
| 110971432 | 11097143 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110971432 | 11097143 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110971432 | 11097143 | Chest pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110971432 | 11097143 | 1 | 200601 | 0 | ||
| 110971432 | 11097143 | 3 | 20070206 | 20070504 | 0 | |
| 110971432 | 11097143 | 6 | 200601 | 0 | ||
| 110971432 | 11097143 | 7 | 200601 | 0 | ||
| 110971432 | 11097143 | 8 | 200201 | 0 | ||
| 110971432 | 11097143 | 9 | 2004 | 0 | ||
| 110971432 | 11097143 | 10 | 2004 | 0 | ||
| 110971432 | 11097143 | 11 | 20070504 | 20070504 | 0 | |
| 110971432 | 11097143 | 12 | 20070504 | 20070504 | 0 | |
| 110971432 | 11097143 | 13 | 20070504 | 20070504 | 0 |